Live Webinar: AI Takes Center Stage – How Disruptive Innovation is Reshaping the New Ecosystem of Innovative Drug Development

May 14, 2025 20:03 CST Updated 20:03

XtalPi

Computation-Driven Innovative Drug R&D Provider

*For medical professionals only

In the midst of surging technological advancements, the field of innovative drug development is undergoing a profound transformation driven by AI. AI-powered drug discovery has bridged the gap between theory and practice, taking root in every stage of the drug development process. From the precise identification of drug targets, to the efficient design of drug molecules, to the optimized advancement of clinical trials, AI is injecting unprecedented vitality and efficiency into innovative drug research with its powerful computing capabilities, accurate analytical abilities, and unique algorithms, ushering in a new era filled with infinite possibilities.

To this end, "Pharmaceutical Innovation"Special Guest Three"Heavyweight Guests in the IndustryIn a live video format, jointly discuss: How AI's "remarkable capabilities" and disruptive power are reshaping the new ecosystem of innovative drugs?

The experts participating in this live interview are:

Dr. La Li-peng:Co-founder and Chief Innovation Officer of XtalPi

Dr. Hua Feng Xu:Co-founder and CEO of Atommap

Dr. Yaning Wang:Founder and CEO of Shanghai Rui Ning Kang Biopharmaceuticals, Former Director of the FDA's Clinical Quantitative Pharmacology Review Department

Please stay tuned.

May 15Day（Thursday）

Beijing Time 19:30-20:30

Eastern Time 7:30-8:30

“Drug Innovation”Video Channel, Medical Circle Weibo, Doctor Station APP ThroughoutSynchronizationLive Streaming

(One-click to schedule live streaming)